Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
92.50    5.00 (5.71%)
Bid:
90.00
Ask:
95.00
Spread: 5.00 (5.556%)
Market Cap: £6.08m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Interim Results

22 Sep 2016 07:00

RNS Number : 4804K
Crimson Tide PLC
22 September 2016
Β 
Crimson Tide plcΒ ("Crimson Tide" or "the Company")Β Interim Results for the six months ended 30 June 2016Β Crimson Tide, a leading service provider of mobile data solutions for business (AIM: TIDE.L) announces its unaudited interim results for the six months ended 30 June 2016.Β HighlightsΒ Β· Profit Before Tax doubled to Β£122k (1H 2015: Β£60k);

Β 

Β· Revenues 25% up on 1H 2015 (Β£845k vs. Β£673k)

Β 

Β· More significant customers addedΒ Β· Balance Sheet reconstruction completed

Β 

Β 

Β 

Barrie Whipp, Executive Chairman, commented,Β "We have continued to build and grow mpro5 into, in our opinion, the leading full service mobility service for organisations. We are expanding our team and our footprint and commencing an investment programme for further growth, both in our existing markets and overseas."Β 

Β 

Β Enquiries:Β 
Crimson Tide plc Barrie Whipp / Steve GoodwinΒ 01892 542444
WH Ireland Limited James Joyce / James BavisterΒ Β 020 7220 1666
Β Β 
Β Β Chairman's StatementΒ I am very pleased to report on the Company's progress for the first half of 2016. Once again, we exceeded all of our key indicators and of particular note, Profit after Tax for the period increased by 100% to Β£122k on increased turnover. We have achieved record subscriber numbers but our most recent contract wins are enterprise level agreements which place less relevance on user numbers and more on net revenues.

Β 

We have consolidated agreements with leading facilities management groups and can report that mpro5 is used in over 15,000 sites in the UK and Ireland. Our long term revenue has continued to increase and is underpinned by significant contracts. Our retail implementations have gone well and there is more opportunity in this sector, where we are offering new solutions to our clients.

Β 

Our growth is reflected not only in profitability but also in terms of cash where we are well placed. Lombard Technical Services continue to support our contracts where devices are required and we remain confident of our ability to fulfil contract wins.

Β 

We are now starting to invest in expansion of our sales channels in the UK and overseas with confidence. We expect this strategy to start to bear more fruit late in the second half and the coming year and is focused upon four or five areas where we believe that mpro5 can fulfil demand.

Β 

I am encouraged by our activities with Vodafone in Ireland and we are hopeful of expanding this relationship in the UK and overseas.

Β 

Technically mpro5 is in extremely good shape. We have added modules to the service based upon customer demand and have an extremely high satisfaction rating. We are currently working on a significant platform change for the mobile application investing in the latest Angular 2 framework. We are also adding Internet of Things capabilities into mpro5 and have a new proprietary alerting platform, which has replaced a third party product, thereby increasing margins further.

Β 

In the healthcare world, we are progressing with a range of transactions and are hopeful of further news soon. There is little doubt that pharma offers enormous opportunities for mpro5. Our capital reorganisation was successful and allows the Directors to recommend a dividend when appropriate.

Β 

The board is extremely pleased with the Company's progress. The positive decision to invest in further growth opportunities is designed to grow our top line revenues which, with our high margins, should see bottom line improvements after absorbing short term increases in sales and marketing overhead. For the first time we will see Crimson Tide with sales channels outside the UK & Ireland. We are excited for the future. Β Barrie WhippExecutive Chairman22 September 2016Β Β Operating and Financial ReviewΒ 

I am pleased to review our operating and financial performance over the first half of 2016 and comment on our results for the six months to 30 June 2016.

Β 

Β 

Operating Review

Β 

The year commenced on a very positive note following the earlier than expected full rollout of the Company's mpro5 solution with one of the country's leading retailers. This highlighted two factors; one, the ease with which we were able to organise and install our mpro5 solution nationwide and two, the value placed on mpro5 by our customers, immediately allowing them to reap the operational and financial benefits from adopting the solution. mpro5 has since started to be implemented elsewhere in the retail sector and we announced in July 2016 a new pilot with another retailer to monitor store safety, cleanliness and security.

Β 

The flexibility of our mpro5 solution means it is able to generate value across a wide range of different markets. Elsewhere, in healthcare, we remain very encouraged by the number of opportunities we are working on including a pilot project for the serialisation and verification of pharmaceutical products. Here, mpro5 provides barcode scanning and cloud‐based synchronisation services via Microsoft Azure, which enables real‐time information to be uploaded, quickly verified and communicated to users. Job scheduling, tracking, bespoke dashboards, all add value ensuring mobile users are able to work most efficiently. Our investment in mpro5 continues and we aim to make sure it remains a leading solution as technological advances continue apace.

Β 

The nature of some of our business is moving to bigger, enterprise solutions. The customer's commitment is unchanged, signing a subscriber agreement for typically an initial thirty-six month term. However, our pricing in these cases reflects the large numbers of users expected. Furthermore, we are finding more opportunities abroad and as mentioned in the Chairman's statement, we are investing in overseas sales resources and related marketing to be able to progress these most effectively. The positive cashflows we are generating together with the security of funding available from Lombard Technical Services to finance devices provided as part of our solution, means the Company's directors are comfortable with this increased expenditure. There may as a result be some short term impact on our rate of profitability growth but we expect over the medium term to generate additional revenues and greater profits.

Β 

Financial Review

Β 

Turnover for the six months to 30 June 2016 increased to Β£845k, up 25% on the same period in 2015. With gross profit margins still over 90% and operating margins before depreciation, amortisation and interest of 33%, up from 29% in 1H 2015, the additional investments previously made in staff have been more than compensated for by increased profitability.

Β 

After depreciation, amortisation and interest costs, the Group achieved a profit of Β£122k in the first half 2016 (1H 2015: Β£60k).

Β 

There have been no changes to Crimson Tide's accounting policies which can be found in the notes to the published 2015 Consolidated Financial Statements available on our website, www.crimsontide.co.uk.

It should be noted, however, that early in 2016, the Company completed its capital reconstruction and now has positive retained earnings in the Balance Sheet to allow the Company to, if appropriate, pay dividends in the future. Shareholders also approved future share buy-backs at the General Meeting, again if thought by the directors to be appropriate. This exercise together with the positive cashflows generated by the Group means the financial position of Crimson Tide looks favourable at the half year and has further improved since as net funds have continued to increase.

Β 

Future Prospects

Β 

The outlook for the business remains very positive. Our mpro5 solution has continually proved a sound investment for our customers even as these customers have become more sizable and/or more geographically spread. The Board and team at Crimson Tide are working hard on behalf of shareholders to ensure that our reputation and success continue to advance.

Β 

Stephen Goodwin

Finance Director

22 September 2016

Β Β Β Crimson Tide plc

Unaudited Consolidated Income Statement for the 6 months to 30 June 2016

Β 

Unaudited

6 Months

ended

30 June

2016

Unaudited

6 Months

ended

30 June

2015

Audited

12 Months

ended 31

December

2015

Β£000

Β£000

Β£000

Revenue

845

673

1,402

Cost of Sales

(71)

(62)

(104)

Gross Profit

774

611

1,298

Overhead expenses

(493)

(413)

(868)

Earnings before interest, tax, depreciation & amortisation

Β 

281

Β 

198

Β 

430

Depreciation & Amortisation

(142)

(132)

(245)

Profit from operations

139

66

185

Interest income

-

-

-

Interest payable and similar charges

(17)

(6)

(17)

Profit before taxation

122

60

168

Taxation

-

-

-

Profit for the year attributable to equity holders of the parent

Β 

122

Β 

60

Β 

168

Earnings per share

Unaudited

6 Months

ended

30 June

2016

Unaudited

6 Months

ended

30 June

2015

Audited

12 Months

ended 31

December

2015

Basic and diluted earnings per Ordinary Share

0.03p

0.01p

0.04p

(see Note 2)

Β 

Β 

Β 

Unaudited Consolidated Statement of Comprehensive Income

for the 6 months to 30 June 2016

Β 

Unaudited

6 Months

ended

30 June

2016

Unaudited

6 Months

ended

30 June

2015

Audited

12 Months

ended 31

December

2015

Β£000

Β£000

Β£000

Profit for the period

122

60

168

Β 

Other comprehensive income/(loss) for period:

Exchange differences on translating foreign operations

1

(5)

(5)

Total comprehensive profit recognised in the period and attributable to equity holders of parent

Β 

123

Β 

55

Β 

163

Β 

Unaudited Consolidated Statement of Financial Position at 30 June 2016

Β 

Unaudited

As at

30 June 2016

Unaudited

As at

30 June 2015

Audited

As at 31 December 2015

Β£000

Β£000

Β£000

Fixed Assets

Intangible assets

1,452

1,308

1,373

Equipment, fixtures & fittings

458

390

527

1,910

1,698

1,900

Current Assets

Inventories

14

11

15

Trade and other receivables

495

346

634

Cash and cash equivalents

661

499

539

Total current assets

1,170

856

1,188

Total assets

3,080

2,554

3,088

Equity and liabilities

Equity

Share capital

447

7,335

7,335

Capital redemption reserve

-

49

49

Share premium

28

1,090

1,090

Other reserves

422

421

421

Reverse acquisition reserve

(5,244)

(5,244)

(5,244)

Retained earnings

6,533

(1,726)

(1,618)

Total Equity

2,186

1,925

2,033

Creditors

Amounts falling due within one year

638

513

806

Β 

Creditors

Amounts falling due after more than one year

256

116

249

Total liabilities

894

629

1,055

Total equity and liabilities

3,080

2,554

3,088

Β 

Β 

Unaudited Consolidated Statement of Changes In Equity at 30 June 2016

Β 

Β 

Β 

Share capital

Capital redemp-tion reserve

Β 

Β 

Share premium

Β 

Β 

Other reserves

Reverse acquisi-tion reserve

Β 

Β 

Retained earnings

Β 

Β 

Β 

Total

Β£000

Β£000

Β£000

Β£000

Β£000

Β£000

Β£000

Balance at 31 December 2014

7,335

49

1,090

426

(5,244)

(1,786)

1,870

Profit for the period

-

-

-

-

-

60

60

Translation movement

-

-

-

(5)

-

-

(5)

Balance at

30 June 2015

Β 

7,335

Β 

49

Β 

1,090

Β 

421

Β 

(5,244)

Β 

(1,726)

Β 

1,925

Balance at 31 December 2015

7,335

49

1,090

421

(5,244)

(1,618)

2,033

Profit for the period

-

-

-

-

-

122

122

Capital reconstruction (*)

(6,890)

(49)

(1,090)

-

-

8,029

-

Share options exercised

2

-

28

-

-

-

30

Translation movement

-

-

-

1

-

-

1

Balance at

30 June 2016

Β 

447

Β 

-

Β 

28

Β 

422

Β 

(5,244)

Β 

6,533

Β 

2,186

(*) At the Company's General Meeting on 26 January 2016 shareholders approved plans to undertake a capital reconstruction, the purpose of which was to create positive retained earnings in the Balance Sheet to allow the Company to, if appropriate, pay dividends in the future. Shareholders also approved future share buy-backs. Following a court hearing on 24 February 2016 the court confirmed the reduction of capital of the Company. The nominal value of each Ordinary Share in the Company reduced from one penny to 0.1 pence per share and the Company's Deferred Shares of 19 pence each, Share Premium Account and Capital Redemption Reserve were cancelled. Trading in the shares with a nominal value of 0.1 pence commenced on 25 February 2016.

Β 

Β 

Unaudited Consolidated Statement of Cashflows for the 6 months to 30 June 2016

Β 

Unaudited

6 Months

ended

30 June

2016

Unaudited

6 Months

ended

30 June

2015

Audited

12 Months

ended

31 December

2015

Β£000

Β£000

Β£000

Cash flows from operating activities

Profit before tax

122

60

168

Adjustments for:

Amortisation of Intangible Assets

48

52

90

Depreciation of equipment, fixtures and fittings

94

80

155

Profit on Sale of Assets

-

-

-

Net Interest

17

6

17

Operating cash flows before movement in working capital and provisions

281

198

430

Decrease in inventories

1

19

15

Decrease/(increase) in trade and other receivables

134

217

(71)

(Decrease)/increase in trade and other payables

(204)

(73)

147

Cash generated from operations

212

361

521

Taxes paid

-

-

-

Net cash generated in operating activities

212

361

521

Cash flows used in investing activities

Purchase of fixed assets

(150)

(230)

(552)

Sale of fixed assets

-

-

-

Interest received

-

-

-

Net cash used in investing activities

(150)

(230)

(552)

Cash flows from financing activities

Net proceeds from issues of shares

30

-

-

Interest paid

(17)

(6)

(17)

Net increase in borrowings

48

135

347

Net cash from/(used in) financing activities

Β 

61

Β 

129

330

Net increase in cash and cash equivalents

123

260

299

Net cash and cash equivalents at beginning of period

538

239

239

Net cash and cash equivalents at end of period

661

499

538

Β 

Β 

Unaudited

6 Months

ended

30 June

2016

Unaudited

6 Months

ended

30 June

2015

Audited

12 Months

ended

31 December

2015

Β£000

Β£000

Β£000

Analysis of net funds:

Cash and cash equivalents

667

499

539

Bank overdraft

(6)

-

(1)

661

499

538

Other borrowings due within one year

(198)

(78)

(157)

Borrowings due after one year

(256)

(116)

(249)

Net funds

207

305

132

Β Β Β Β Crimson Tide Plc

Β 

Notes to the Unaudited Interim Results for the 6 months ended 30 June 2016

Β 

1. Basis of preparation of interim report

Β 

The information for the period ended 30 June 2016 does not constitute statutory accounts as defined in section 434 of the Companies Act 2006. It has been prepared in accordance with the accounting policies set out in, and is consistent with, the audited financial statements for the twelve months ended 31 December 2015. A copy of the statutory accounts for that period has been delivered to the Registrar of Companies. The auditor's report on those accounts was unqualified and did not contain statements under Section 498 (2) or (3) of the Companies Act 2006.

Β 

2. Earnings per share

Β 

The calculation of the basic earnings per share is based on the profit attributable to ordinary shareholders and the weighted average number of ordinary shares in issue during the period.

Β 

The calculation of the diluted earnings per share is based on the profit per share attributable to ordinary shareholders and the weighted average number of ordinary shares that would be in issue, assuming conversion of all dilutive potential ordinary shares into ordinary shares.

Β 

Reconciliations of the profit and weighted average number of ordinary shares used in the calculation are set out below:

Β 

Β 

Β Unaudited

Β 6 Months

ended

30 June

2016

Β 

Β 

Unaudited

Β 6 Months

ended

30 June

2015

Β 

Β 

Audited

Β 12 Months

ended 31

December

2015

Β 

Basic and diluted earnings per share

Reported profit (Β£000)

122

60

168

Reported profit per share (pence)

0.03

0.01

0.04

Β 

Β 

Unaudited

Β 6 Months

ended

30 June

2016

Β 

Β 

Unaudited

Β 6 Months

ended

30 June

2015

Β 

Β 

Audited

Β 12 Months

ended 31

December

2015

Β 

No. 000

No. 000

No. 000

Weighted average number of ordinary shares:

Shares in issue at start of period

445,486

445,486

445,486

Effect of shares issued during the period

197

-

-

Weighted average number of ordinary shares

Β 

445,683

Β 

445,486

Β 

445,486

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IR UAOSRNSAKUAR
Date   Source Headline
4th Jan 20235:00 pmRNSHolding(s) in Company
1st Dec 20227:00 amRNSDirector dealing
17th Nov 20227:00 amRNSSignificant contract expansion and extension
27th Sep 20227:00 amRNSInterim Results
25th Aug 20227:00 amRNSDirector Dealing
3rd Aug 20227:00 amRNSChange of Auditor
2nd Aug 20227:00 amRNSBoard Changes
25th Jul 20227:00 amRNSContract Win
19th Jul 20227:00 amRNSMultiyear contract win with major wholesaler
30th Jun 202211:27 amRNSResults of AGM & Statement
16th Jun 20224:30 pmRNSAnnual Report and Notice of AGM
7th Apr 20227:00 amRNSPreliminary Results
10th Feb 20227:00 amRNSContract Win and Strategic Partnership
3rd Feb 20227:00 amRNSTrading Update
7th Dec 20217:00 amRNSMaster Service Agreement with Compass Group
12th Nov 20217:00 amRNSDirectorate Change
11th Oct 202110:59 amRNSPDMR Dealing
28th Sep 20217:00 amRNSInterim Results
29th Jun 20213:08 pmRNSResult of AGM
16th Jun 20217:00 amRNSNorth America Appointment
4th Jun 20217:00 amRNSAnnual Report and Notice of AGM
4th May 20212:22 pmRNSTotal Voting Rights
28th Apr 202110:34 amRNSHolding(s) in Company
27th Apr 20217:00 amRNSHolding(s) in Company
26th Apr 20217:00 amRNSHolding(s) in Company
23rd Apr 20214:25 pmRNSHolding(s) in Company
23rd Apr 202110:37 amRNSPDMR Dealings
23rd Apr 202110:36 amRNSHolding(s) in Company
22nd Apr 202111:45 amRNSResult of General Meeting and Total Voting Rights
20th Apr 20217:00 amRNSContract Win
1st Apr 20213:52 pmRNSResult of Placing
1st Apr 202112:01 pmRNSPlacing to raise up to £6.0 million
1st Apr 202112:00 pmRNSPreliminary Results
18th Mar 20217:00 amRNSContract Win
1st Feb 20219:28 amRNSHolding(s) in Company
28th Jan 20217:00 amRNSAppointment of Director
26th Jan 20217:00 amRNSPilot with World Federation of Haemophilia
18th Jan 20219:36 amRNSHolding(s) in Company
12th Jan 20214:07 pmRNSHolding(s) in Company
7th Jan 20212:30 pmRNSHolding(s) in Company
23rd Dec 202012:15 pmRNSClarification re Grant of Options
22nd Dec 202010:45 amRNSGrant of Options under the Company's EMI Scheme
4th Dec 202011:35 amRNSHolding(s) in Company
17th Nov 20207:00 amRNSContract Wins
12th Nov 20204:27 pmRNSDirector/PDMR Shareholding
6th Nov 20201:15 pmRNSPDMR dealing
26th Oct 202010:08 amRNSHolding(s) in Company
5th Oct 20209:16 amRNSHolding(s) in Company
18th Sep 20207:00 amRNSInterim Results
14th Sep 20202:06 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.